Antibacterial Activity of Ticagrelor Against Resistant Gram-Positive Bacteria

https://jamanetwork.com/journals/jamacardiology/fullarticle/2732487

This study uses in vitro assays and a mouse model to investigate antibacterial properties of ticagrelor to follow up findings from 2 clinical trials that showed patients taking ticagrelor for cardiovascular disease had a lower risk of infection-related death and improved lung function compared with patients treated with clopidogrel.

Ryan
Ryan

No Comments

Write a Reply or Comment